Table 1.
Baseline characteristics of the clinical variables of 305 patients with COVID-19
| Total (n = 305) | Survivor (n = 245) | Non-survivor (n = 60) |
|---|---|---|
| Sex | ||
| Men | 109 (44.5%) | 40 (66.7%) |
| Women | 136 (55.5%) | 20 (33.3%) |
| Fever | ||
| Yes | 191 (78.0%) | 47 (78.3%) |
| No | 54 (22.0%) | 13 (21.7%) |
| Dizziness | ||
| Yes | 14 (5.7%) | 3 (5.0%) |
| No | 231 (94.3%) | 57 (95.0%) |
| Fatigue | ||
| Yes | 117 (47.8%) | 34 (56.7%) |
| No | 128 (52.2%) | 26 (43.3%) |
| Nausea | ||
| Yes | 24 (9.8%) | 4 (6.7%) |
| No | 221 (90.2%) | 56 (93.3%) |
| Diarrhea | ||
| Yes | 43 (17.6%) | 12 (20.0%) |
| No | 202 (82.4%) | 48 (80.0%) |
| Muscle pain | ||
| Yes | 49 (20.0%) | 9 (15.0%) |
| No | 196 (80.0%) | 51 (85.0%) |
| Confusion | ||
| Yes | 9 (3.7%) | 9 (15.0%) |
| No | 236 (96.3%) | 51 (85.0%) |
| Difficulty in breathing | ||
| Yes | 135 (55.1%) | 41 (68.3%) |
| No | 110 (44.9%) | 19 (31.7%) |
| Cough | ||
| Yes | 158 (64.5%) | 41 (68.3%) |
| No | 87 (35.5%) | 19 (31.7%) |
| Expectoration | ||
| Yes | 73 (29.8%) | 24 (40.0%) |
| No | 172 (70.2%) | 36 (60.0%) |
| CT: exudative lesion | ||
| Yes | 58 (23.7%) | 12 (20.0%) |
| No | 187 (76.3%) | 48 (80.0%) |
| CT: ground glass shadow | ||
| Yes | 52 (21.2%) | 5 (8.3%) |
| No | 193 (78.8%) | 55 (91.7%) |
| Hypertension | ||
| Yes | 41 (16.7%) | 16 (26.7%) |
| No | 204 (83.3%) | 44 (73.3%) |
| Accouchement | ||
| Yes | 15 (6.1%) | 0 (0.0%) |
| No | 230 (93.9%) | 60 (100.0%) |